IBIO SCHEDULE 13G/A: SEC filing

Frazier Life Sciences Public Fund, L.P. and affiliated entities

Filed with the SEC on · accession 0001231919-26-001582

IBIO filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Nov 16, 2026. Frazier Life Sciences Public Fund, L.P. and affiliated entities filed an amended Schedule 13G reporting beneficial ownership of 1,953,467 shares, or 3.0%, of iBio, Inc.'s common stock as of September 30, 2026. The stock moved -3.4% by the first close after the filing.

Summary of the filing

Frazier Life Sciences Public Fund, L.P. and affiliated entities filed an amended Schedule 13G reporting beneficial ownership of 1,953,467 shares, or 3.0%, of iBio, Inc.'s common stock as of September 30, 2026. The filing also discloses holdings of pre-funded warrants to purchase additional shares, which are subject to a 9.99% beneficial ownership cap.

Key details

Shares of common stock beneficially owned by Frazier Life Sciences Public Fund, L.P.$2.0M
Percentage of outstanding common stock beneficially owned$3
Pre-funded warrants held by Frazier Life Sciences Public Fund, L.P. to purchase common stock$7.6M
Pre-funded warrants held by Frazier Life Sciences XI, L.P. to purchase common stock$71K
Pre-funded warrants held by Frazier Life Sciences XII, L.P. to purchase common stock$886K
Shares of common stock outstanding as of September 30, 2026$64.3M
Reporting person / beneficial ownerFrazier Life Sciences Public Fund, L.P.
General partner of frazier life sciences public fund, l.p.FHMLSP, L.P.
General partner of fhmlsp, l.p.FHMLSP, L.L.C.
Reporting person / warrant holderFrazier Life Sciences XI, L.P.
Reporting person / warrant holderFrazier Life Sciences XII, L.P.
IssueriBio, Inc.

How IBIO stock reacted

Close before

$0.73

Nov 13, 2026

First close after

-3.42%

$0.71

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for IBIO, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for IBIO?

Click here

Frequently asked questions

What did IBIO file with the SEC on Nov 16, 2026?

IBIO filed a SCHEDULE 13G/A (SEC filing). Frazier Life Sciences Public Fund, L.P. and affiliated entities filed an amended Schedule 13G reporting beneficial ownership of 1,953,467 shares, or 3.0%, of iBio, Inc.'s common stock as of September 30, 2026. The filing also discloses holdings of pre-funded warrants to purchase additional shares, which are subject to a 9.99% beneficial ownership cap.

How do I read a SCHEDULE 13G/A?

A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).

How did IBIO stock react to this filing?

IBIO closed at $0.73 before the filing and $0.71 on Nov 16, 2026 (-3.42%).

Other IBIO SEC filings

Get alerts when IBIO files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days